Clearlake Capital-backed TEAM Technologies completed the acquisition of iiMED from ACON Investments.

Clearlake Capital-backed TEAM Technologies, a healthcare specialty manufacturer, completed the acquisition of iiMED, a specialty manufacturer of FDA Class I & II consumable medical devices, from ACON Investments, an international private equity investment company. Financial terms were not disclosed. "We are thrilled to welcome iiMED's customer partners and talented employees to the TEAM family. We have been impressed with iiMED's rapid growth and deep expertise across an array of specialty manufacturing solutions, and we look forward to working with the iiMED team to grow our combined business to better serve our healthcare customers. As our communities continue working through the implications of severe supply chain constraints and disruption, TEAM remains committed to building a North American footprint of scale and manufacturing excellence to aid our customers in their pursuit of enhanced procurement continuity and accelerated time-to-market for their critical healthcare solutions," Marshall White, TEAM President and CEO.